GILEAD SCIENCES, INC. — Director's Dealing 2015

Jul 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-07-01

Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-01	Common Stock	M	15000	$23.755	Acquired	156422	Direct
2015-07-01	Common Stock	S	6830	$115.9447	Disposed	149592	Direct
2015-07-01	Common Stock	S	4907	$117.0062	Disposed	144685	Direct
2015-07-01	Common Stock	S	3263	$117.9243	Disposed	141422	Direct
2015-07-01	Common Stock	S	765	$115.9139	Disposed	140657	Direct
2015-07-01	Common Stock	S	700	$116.9029	Disposed	139957	Direct
2015-07-01	Common Stock	S	535	$117.9456	Disposed	139422	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-01	Non-Qualified Stock Option (right to buy)	$23.755	M	15000	Disposed	2020-01-28	Common Stock (15000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $115.4991 to $116.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $116.5456 to $117.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $117.60 to $118.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F6: Sale prices reported for the transactions reported here range from $115.46 to $116.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F7: Sale prices reported for the transactions reported here range from $116.59 to $117.19. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F8: Sale prices reported for the transactions reported here range from $117.61 to $118.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.